A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes
Public ClinicalTrials.gov record NCT05785832. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ+ Technology in Adults With Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP)
Study identification
- NCT ID
- NCT05785832
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Tandem Diabetes Care, Inc.
- Industry
- Enrollment
- 319 participants
Conditions and interventions
Conditions
Interventions
- Standard Therapy plus continuous glucose monitoring (CGM) Device
- t:slim X2 insulin pump with Control-IQ+ technology and Dexcom G6 CGM Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2023
- Primary completion
- Sep 23, 2024
- Completion
- Sep 23, 2024
- Last update posted
- Feb 18, 2026
2023 – 2024
United States locations
- U.S. sites
- 19
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92663 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30303 | — |
| Rocky Mountain Clinical Research | Idaho Falls | Idaho | 83404 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Baltimore VA Medical Center | Baltimore | Maryland | 21201 | — |
| Boston Medical Center Corporation | Boston | Massachusetts | 02118 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Icahn School of Medicine at Mt. Sinai | New York | New York | 10029 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| UHH Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Texas Diabetes and Endocrinology, P.A. | Austin | Texas | 78731 | — |
| University of Texas Southwestern | Dallas | Texas | 75013 | — |
| Diabetes & Endocrine Treatment Specialists | Sandy City | Utah | 84093 | — |
| University of Virginia | Charlottesville | Virginia | 22903 | — |
| Rainier Clinical Research Center | Renton | Washington | 98057 | — |
| University of Washington | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05785832, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 18, 2026 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05785832 live on ClinicalTrials.gov.